Head-to-head · WeighScore
JRNYS vs TeleZen MD
The verdict
JRNYS takes it — 62.5/100 to 60.2/100.
JRNYS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. JRNYS is a telehealth weight-loss membership built around branded GLP-1 medications, and the membership itself buys no medication.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | JRNYS | TeleZen MD |
|---|---|---|
| WeighScore | 62.5/100 | 60.2/100 |
| Grade | C | C |
| Scorecard rank | #271 | #329 |
| Semaglutide | Not disclosed | $198/mo (compounded) |
| Tirzepatide | Not disclosed | $298/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #271 · C
Strengths
- Branded, FDA-approved GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro and Saxenda — rather than compounded copies
- The membership band is published before intake and is banded openly by level of coach support
- Medical visits, daily monitoring and 1-on-1 coaching are included in the membership at every tier
- Led by CMO Dr. Henry Legere (UC Berkeley, Columbia medicine, Harvard fellowship)
- Members with commercial insurance may pay around $25 a month for the medication after any deductible
Where it loses points
- The membership is overhead, not a medication price: it covers visits, monitoring and coaching, and the FAQ says medication pricing is confirmed only after a provider consultation
- No self-pay drug price is published anywhere, so the cost of a month cannot be worked out before signing up
- The best case depends on commercial insurance coverage; without it the medication cost is unknown
- No compounded option is disclosed — the programme is brand-focused, and brand list prices are the dearest route to a GLP-1
- The states it can prescribe in are not published
Graded #329 · C
Strengths
- Says it serves all 50 states — among the broadest claimed reach in the compounded segment
- Markets U.S.-based, FDA-registered pharmacies
- $100 off your first order with code WELCOME100
- Fully online U.S. telehealth model with physician evaluation
- Education-forward, physician-led positioning
Where it loses points
- Partner pharmacy not named
- Legal entity name and state of incorporation not disclosed
- Brand-name medications not addressed on the homepage
- LegitScript certification not confirmed
- All-50-states claim is the provider's own, not independently verified
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.